Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Syndax Pharmaceuticals (Nasdaq: SNDX) announced inducement stock option awards on April 1, 2026, granting up to 228,500 shares to eight new employees under its 2023 Inducement Plan.

Rhea-AI Summary

Syndax Pharmaceuticals (Nasdaq: SNDX) announced inducement stock option awards on April 1, 2026, granting up to 228,500 shares to eight new employees under its 2023 Inducement Plan.

The options vest over four years: 25% at one year, then monthly vesting over 36 months, subject to continued service.

Argus Apr 6 session

-3.42% close to close Open Argus

Details

News Market Reaction – SNDX

In the Apr 6 session, SNDX declined 3.42%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement details routine equity compensation, granting stock options for 228,500 shares to ...

Analysis

This announcement details routine equity compensation, granting stock options for 228,500 shares to eight new employees under the 2023 Inducement Plan, vesting over 4 years with a 25% first-year cliff and monthly vesting thereafter. It follows a prior inducement grant disclosed on Mar 04, 2026, reinforcing a consistent approach to attracting and retaining talent. Investors may focus more on revenue growth, commercial execution, and upcoming trial milestones when assessing the broader equity story.

Key Figures

Inducement option grants: 228,500 shares New employees: 8 employees Vesting period: 4 years +5 more

Inducement option grants

228,500 shares

Stock options granted to eight new employees on April 1, 2026

New employees

8 employees

Recipients of inducement stock option awards

Vesting period

4 years

Total vesting term for inducement stock options

Initial cliff vesting

25%

Options vest on one-year anniversary of vesting commencement date

Monthly vesting fraction

1/48th

Portion of options vesting monthly after first year

Subsequent vesting duration

36 months

Monthly vesting period following the first-year cliff

Price change pre-news

5.32%

Share price move in the last 24 hours before this release

52-week performance

193.12% above low

Price versus 52-week low before this announcement

Historical Context

5 past events · Latest: Mar 04

5 events

1. Mar 04

   Inducement grants

   24h Move

   -0.2%

   Options for 81,600 shares granted to three new employees under inducement plan.

2. Feb 26

   Earnings and update

   24h Move

   +5.0%

   Reported Q4 and FY 2025 revenue with strong contributions from Revuforj and Niktimvo.

3. Feb 23

   Conference participation

   24h Move

   +1.1%

   Announced participation in multiple March 2026 investor conferences with CEO fireside chats.

4. Feb 19

   Earnings date notice

   24h Move

   +1.9%

   Set date and time for Q4 and full-year 2025 earnings call and webcast.

5. Feb 05

   Conference appearance

   24h Move

   -1.4%

   CEO scheduled for fireside chat at Guggenheim biotech summit with webcast access.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

nasdaq listing rule 5635(c)(4), inducement plan, stock options

3 terms

nasdaq listing rule 5635(c)(4) regulatory

"Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)"

NASDAQ Listing Rule 5635(c)(4) is a rule that requires a company to get approval from its shareholders before selling a large amount of its shares, usually over 20%. This helps protect investors by making sure the company doesn't flood the market with new shares without their say, which could lower the stock's value.

inducement plan financial

"to eight new employees under the Company's 2023 Inducement Plan."

An inducement plan is a program a company creates to encourage employees or new hires to stay or join by offering special benefits or rewards. It’s like a company giving extra bonuses or perks to persuade someone to choose their job over others, helping the company attract and keep talented workers.

stock options financial

"The stock options will vest over four years, with 25% of the underlying shares vesting"

Stock options are agreements that give a person the right to buy or sell a company's stock at a specific price within a certain time frame. They are often used as a reward or incentive, similar to a coupon that can be used later if the stock price rises, allowing the holder to make a profit.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

NEW YORK, April 03, 2026 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that on April 1, 2026, the Company granted inducement awards to purchase up to 228,500 shares of common stock to eight new employees under the Company's 2023 Inducement Plan. The stock options will vest over four years, with 25% of the underlying shares vesting on the one-year anniversary of the vesting commencement date and 1/48th of the underlying shares vesting monthly thereafter over 36 months, subject to the employee's continued service relationship with Syndax through the applicable vesting dates.

About Syndax
Syndax Pharmaceuticals is a commercial-stage biopharmaceutical company advancing innovative cancer therapies. Highlights of the Company's pipeline include Revuforj^® (revumenib), an FDA-approved menin inhibitor, and Niktimvo™ (axatilimab-csfr), an FDA-approved monoclonal antibody that blocks the colony stimulating factor 1 (CSF-1) receptor. Fueled by our commitment to reimagining cancer care, Syndax is working to unlock the full potential of its pipeline and is conducting several clinical trials across the continuum of treatment. For more information, please visit www.syndax.com or follow the Company on X and LinkedIn.

Syndax Contact

Sharon Klahre 
Syndax Pharmaceuticals, Inc. 
sklahre@syndax.com
Tel 781.684.9827

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Syndax (SNDX) announce on April 1, 2026 about inducement grants?

Syndax granted inducement stock options to eight new employees totaling up to 228,500 shares. According to the company, the awards were made under the 2023 Inducement Plan and intended to recruit new personnel.

How do the Syndax SNDX inducement options vest and when do they start?

The options vest over four years with 25% vesting at one year and monthly thereafter. According to the company, 1/48th vests each month over the remaining 36 months, subject to continued service.

How many employees received Syndax (SNDX) inducement awards on April 1, 2026?

Eight new employees received inducement awards under the 2023 Inducement Plan. According to the company, the grants are intended as hiring inducements for newly hired staff.

What is the total share count of the SNDX inducement awards and how might that affect shareholders?

The awards total up to 228,500 shares of common stock granted as options. According to the company, the options are standard inducements; the release did not state any immediate cash impact or dilution percentage.

Under which plan were the Syndax (SNDX) inducement stock options granted?

The options were granted under the company's 2023 Inducement Plan to comply with Nasdaq rules. According to the company, the plan permits awards to newly hired employees as recruiting inducements.